Perrigo Debt to Equity Ratio 2010-2025 | PRGO

Current and historical debt to equity ratio values for Perrigo (PRGO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Perrigo debt/equity for the three months ending March 31, 2025 was 0.82.
Perrigo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $5.40B $4.36B 1.24
2024-12-31 $5.33B $4.32B 1.23
2024-09-30 $6.64B $4.57B 1.45
2024-06-30 $5.85B $4.55B 1.29
2024-03-31 $5.95B $4.69B 1.27
2023-12-31 $6.04B $4.77B 1.27
2023-09-30 $6.02B $4.74B 1.27
2023-06-30 $6.12B $4.85B 1.26
2023-03-31 $6.12B $4.83B 1.27
2022-12-31 $6.18B $4.84B 1.28
2022-09-30 $6.08B $4.60B 1.32
2022-06-30 $6.07B $4.85B 1.25
2022-03-31 $5.29B $5.11B 1.04
2021-12-31 $5.27B $5.15B 1.02
2021-09-30 $5.73B $5.18B 1.11
2021-06-30 $5.72B $5.51B 1.04
2021-03-31 $5.77B $5.56B 1.04
2020-12-31 $5.83B $5.66B 1.03
2020-09-30 $5.76B $5.82B 0.99
2020-06-30 $6.22B $5.91B 1.05
2020-03-31 $5.61B $5.79B 0.97
2019-12-31 $5.50B $5.80B 0.95
2019-09-30 $5.55B $5.76B 0.96
2019-06-30 $5.70B $5.73B 1.00
2019-03-31 $5.42B $5.70B 0.95
2018-12-31 $5.32B $5.67B 0.94
2018-09-30 $5.28B $5.66B 0.93
2018-06-30 $5.33B $5.90B 0.90
2018-03-31 $5.43B $6.21B 0.88
2017-12-31 $5.46B $6.17B 0.89
2017-09-30 $5.80B $6.04B 0.96
2017-06-30 $5.71B $6.08B 0.94
2017-03-31 $7.91B $6.07B 1.30
2016-12-31 $7.91B $5.96B 1.33
2016-09-30 $8.41B $7.48B 1.12
2016-06-30 $9.24B $9.05B 1.02
2016-03-31 $9.77B $9.73B 1.01
2015-12-31 $9.24B $10.11B 0.92
2015-09-30 $8.97B $10.73B 0.84
2015-06-30 $9.06B $10.66B 0.85
2015-03-31 $6.60B $9.59B 0.69
2014-12-31 $6.75B $9.72B 0.69
2014-09-30 $5.06B $8.72B 0.58
2014-06-30 $5.19B $8.69B 0.60
2014-03-31 $5.18B $8.56B 0.61
2013-12-31 $5.21B $8.50B 0.61
2013-09-30 $3.04B $2.47B 1.23
2013-06-30 $3.02B $2.33B 1.29
2013-03-31 $2.27B $2.23B 1.02
2012-12-31 $2.19B $2.11B 1.04
2012-09-30 $2.15B $1.97B 1.10
2012-06-30 $2.17B $1.85B 1.17
2012-03-31 $2.27B $1.77B 1.28
2011-12-31 $2.31B $1.63B 1.42
2011-09-30 $1.97B $1.54B 1.28
2011-06-30 $1.66B $1.53B 1.08
2011-03-31 $1.61B $1.43B 1.13
2010-12-31 $1.63B $1.31B 1.24
2010-09-30 $1.57B $1.21B 1.30
2010-06-30 $2.02B $1.09B 1.84
2010-03-31 $1.43B $1.06B 1.35
2009-12-31 $1.47B $0.99B 1.49
2009-09-30 $1.44B $0.96B 1.50
2009-06-30 $1.61B $0.92B 1.75
2009-03-31 $1.53B $0.84B 1.82
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.643B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.835B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 15.40
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00